期刊文献+

低浓度丝裂霉素C与曲安奈德治疗瘢痕疙瘩的应用观察 被引量:1

The therapy function of low concentration mitomycin C associate with steroid to keloid
原文传递
导出
摘要 目的观察低浓度丝裂霉素C与糖皮质激素联合局部注射治疗瘢痕疙瘩的疗效及安全性。方法研究分两组,单纯激素治疗组48例瘢痕疙瘩患者进行单纯曲安奈德注射瘢痕内注射,1次/2周。联合治疗组42例瘢痕疙瘩患者将0.04mg丝裂霉素C与5ml曲安奈德、1ml2%利多卡因混合后局部注射于瘢痕全层,1次/2~4周。瘢痕完全萎缩后逐渐降低药物浓度并延长注射间歇期。结果在治疗6个月以上的患者中,丝裂霉素c联合糖皮质激素治疗瘢痕疙瘩的总有效率为97.62%,其中完全缓解者占45.23%,极大缓解者占47.62%,部分缓解者占4.72%,未缓解者为2.38%。结论低浓度丝裂霉素C与糖皮质激素联合局部注射治疗瘢痕疙瘩的疗效显著。 Objective To monitor the therapeutic action and security of mitomyein C associate with steroid injected to keloid. Methods 48 patients were treated merely with eortieosteroid injection to keloid, once in 2weeks. The other 42 patients around sternal area were treated with intralesional injection of a mixture of 0. 04 mg mitomycin C ,5 ml eortieosteroid and 1 ml 2% lidocaine once per 2-4 weeks. After keloid r became flattened, drug concentration was deereased with prolonged intermission of drug injection. Results' The total therapy effi- cacy of mitomyein C associate with steroid to keloid was 97.62%. the complete remission percentage was 45.23%, the large remission percentage was 47.62%, part remission percentage was 4.72%, and the inefficacy percentage was 2. 38%. Conclusion It is more effective that the combination therapy to keloid of low concen- tration mitomvcin C and steroid.
作者 王旭东
出处 《中国临床实用医学》 2010年第5期93-94,共2页 China Clinical Practical Medicine
关键词 瘢痕疙瘩 丝裂霉素C 糖皮质激素 Keloid Mitomycin C Steroid
  • 相关文献

参考文献5

二级参考文献17

  • 1邱林,向代理,傅跃先,田晓菲,刘燕.激素局部注射治疗儿童瘢痕的疗效分析[J].临床小儿外科杂志,2003,2(6):430-432. 被引量:6
  • 2武晓莉,刘伟,曹谊林.低浓度5-氟尿嘧啶抑制血管增生在瘢痕疙瘩综合治疗中的作用初探[J].中华整形外科杂志,2006,22(1):44-46. 被引量:44
  • 3Urioste SS,Arndt KA,Dover JS.Keloids and hypertrophic scars:review and treatment strategies.Semin Cutan Med Surg,1999,18:159-171.
  • 4Berman B,Bieley HC.Keloids.J Am Acad Dermatol,1995,33:117-123.
  • 5Alster TS,Handrick C.Laser treatnent of hypertrophic scars,keloids,and striae.Semin Cutan Med Surg,2000,19:287-292.
  • 6Fitzpatrick RE.Treatment of inflamed hypertrophic scars using intralesional 5-FU.Dermatol Surg,1999,25:224-232.
  • 7Mustoe TA,Cooter RD,Gold MH,et al.International clinical recommendations on scar management.Plast Reconstr Surg,2002,110:560-571.
  • 8Gupta S,Kalra A.Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids.Dermatology,2002,204:130-132.
  • 9DOONG H,DISSANAYAKE S,GOWRISHANKAR TR,et al.The 1996 Lindberg Award.Calcium antagonists alter cell shape and induce procolla-genase synthesis in keloid and normal human dermal fihroblasts[J].J Bum Care Rehabil,1996,17(6 Pt 1):497-514.
  • 10SCLAFANI AP,GORDON L,CHADHA METAL,et al.Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy:a randomized prospectire stu 勿 and review of the literature[J].Ikrmatol Surg,1996,22(2):569-576.

共引文献44

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部